BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 14634494)

  • 1. Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs.
    Petrakis IL; Leslie D; Rosenheck R
    Alcohol Clin Exp Res; 2003 Nov; 27(11):1780-4. PubMed ID: 14634494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study.
    Iheanacho T; Issa M; Marienfeld C; Rosenheck R
    Drug Alcohol Depend; 2013 Sep; 132(1-2):122-6. PubMed ID: 23434041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
    Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
    Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
    Krystal JH; Gueorguieva R; Cramer J; Collins J; Rosenheck R;
    Alcohol Clin Exp Res; 2008 Jan; 32(1):85-91. PubMed ID: 18070245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population.
    Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ
    J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do patients with alcohol dependence use more services? A comparative analysis with other chronic disorders.
    Fortney JC; Booth BM; Curran GM
    Alcohol Clin Exp Res; 1999 Jan; 23(1):127-33. PubMed ID: 10029213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of nursing home admission in association with mental illness nationally in the Department of Veterans Affairs.
    Miller EA; Rosenheck RA
    Med Care; 2006 Apr; 44(4):343-51. PubMed ID: 16565635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of antidepressants in alcohol-dependent veterans.
    Petrakis IL; Leslie D; Rosenheck R
    J Clin Psychiatry; 2003 Aug; 64(8):865-70. PubMed ID: 12926999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S; Leslie DL; Rosenheck RA
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracing the flow of knowledge: geographic variability in the diffusion of prazosin use for the treatment of posttraumatic stress disorder nationally in the Department of Veterans Affairs.
    Harpaz-Rotem I; Rosenheck RA
    Arch Gen Psychiatry; 2009 Apr; 66(4):417-21. PubMed ID: 19349311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system.
    Fisher DA; Galanko J; Dudley TK; Shaheen NJ
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):991-6. PubMed ID: 17627900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive medication adherence in the Department of Veterans Affairs.
    Siegel D; Lopez J; Meier J
    Am J Med; 2007 Jan; 120(1):26-32. PubMed ID: 17208076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for older veterans diagnosed with posttraumatic stress disorder in Veterans Administration.
    Mohamed S; Rosenheck R
    Am J Geriatr Psychiatry; 2008 Oct; 16(10):804-12. PubMed ID: 18827226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hysterectomy and associated factors in women Veterans Affairs patients.
    Gardella C; Johnson KM; Dobie DJ; Bradley KA
    J Reprod Med; 2005 Mar; 50(3):166-72. PubMed ID: 15841928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental illness and use of home care nationally in the U.S. Department of Veterans Affairs.
    Miller EA; Rosenheck RA
    Am J Geriatr Psychiatry; 2007 Dec; 15(12):1046-56. PubMed ID: 18056823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of childhood abuse on the course of bipolar disorder: a replication study in U.S. veterans.
    Brown GR; McBride L; Bauer MS; Williford WO;
    J Affect Disord; 2005 Dec; 89(1-3):57-67. PubMed ID: 16213029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication adherence and its effect on relapse among patients discharged from a Veterans Affairs posttraumatic stress disorder treatment program.
    Lockwood A; Steinke DT; Botts SR
    Ann Pharmacother; 2009 Jul; 43(7):1227-32. PubMed ID: 19584387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Naltrexone use in the treatment of alcoholism in Spain].
    Rubio Valladolid G; Espí Martínez F; Sanchís Fortea M; Bravo García De Laguna JL
    Rev Clin Esp; 2002 Aug; 202(8):435-9. PubMed ID: 12199993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.